Here’s the big barrier Amazon stock must overcome to reach fresh highs
Read more at MarketWatch
Topics
-
Amazon makes fresh nuclear bet. Is it good news for this year’s hottest stocks?
Business - MarketWatch - October 16 -
Nvidia’s stock hits new high as it reaches this milestone level
Business - MarketWatch - October 21 -
Gold’s record-breaking run comes as stocks hit fresh highs. Is it too late for investors?
Business - MarketWatch - October 19 -
Apple, Meta and Amazon must show the stock market that AI spending is paying off
Business - MarketWatch - 5 days ago -
PayPal beat big on a profit metric, but here’s why its stock is falling
Business - MarketWatch - 6 days ago -
Intel books big charges for restructuring, but here’s why its stock is surging
Business - MarketWatch - 3 days ago -
Dodgers overcome 'most trying year' to defeat Mets and reach the World Series
Sports - Yahoo Sports - October 21 -
Amazon shares pop on earnings beat, cloud growth
Business - CNBC - 4 days ago
More from MarketWatch
-
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago -
Dollar Tree’s CEO steps down. An analyst says the move comes at a ‘difficult time.’
Business - MarketWatch - 2 hours ago -
Super Micro needs a new CEO before its AI advantage erodes
Business - MarketWatch - 3 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 1 hour ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago